Literature DB >> 10377930

The incidence and prevalence of myoclonus in Olmsted County, Minnesota.

J N Caviness1, L I Alving, D M Maraganore, R A Black, S K McDonnell, W A Rocca.   

Abstract

OBJECTIVE: To study the incidence and prevalence of diagnosed myoclonus in Olmsted County, Minnesota. Little is known about the frequency and distribution of myoclonus in the general population.
DESIGN: Descriptive study with case ascertainment through a records-linkage system. PATIENTS AND METHODS: We used a medical records-linkage system to identify all subjects whose records contained documentation of myoclonus or of diseases known to exhibit myoclonus. The records of all potential patients were reviewed by a neurologist, and only patients with pathologic and persistent myoclonus were included. Population denominators were derived from census data.
RESULTS: The average annual incidence rate of pathologic and persistent myoclonus for 1976 through 1990 was 1.3 cases per 100,000 person-years. The rate increased with advancing age and was consistently higher in men. Symptomatic myoclonus was the most common type, followed by epileptic and essential myoclonus; dementing diseases were the most common cause of symptomatic myoclonus. The lifetime prevalence of myoclonus, as of January 1, 1990, was 8.6 cases per 100,000 population, and the prevalence increased with advancing age.
CONCLUSION: Although our figures are probably under-estimated, they are the first attempt, to our knowledge, to measure myoclonus morbidity in the general population. We found clinical features and age and sex distributions different from those previously described in clinical series.

Entities:  

Mesh:

Year:  1999        PMID: 10377930     DOI: 10.4065/74.6.565

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  13 in total

1.  Relative Incidence of Seizures and Myoclonus in Alzheimer's Disease, Dementia with Lewy Bodies, and Frontotemporal Dementia.

Authors:  Alexander J Beagle; Sonja M Darwish; Kamalini G Ranasinghe; Alice L La; Elissaios Karageorgiou; Keith A Vossel
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

2.  Neurological symptoms in individuals with fibrodysplasia ossificans progressiva.

Authors:  Joseph A Kitterman; Jonathan B Strober; Lixin Kan; David M Rocke; Amanda Cali; Jeannie Peeper; Jennifer Snow; Patricia L R Delai; Rolf Morhart; Robert J Pignolo; Eileen M Shore; Frederick S Kaplan
Journal:  J Neurol       Date:  2012-06-30       Impact factor: 4.849

Review 3.  [Myoclonus as a movement disorder].

Authors:  H-M Meinck
Journal:  Nervenarzt       Date:  2017-10       Impact factor: 1.214

4.  Movement disorders at a university hospital emergency room. An analysis of clinical pattern and etiology.

Authors:  Jung Han Yoon; Phil Hyu Lee; Seok Woo Yong; Hee Young Park; Tae Sung Lim; Jun Young Choi
Journal:  J Neurol       Date:  2008-03-14       Impact factor: 4.849

Review 5.  Treatment of myoclonus.

Authors:  John N Caviness
Journal:  Neurotherapeutics       Date:  2014-01       Impact factor: 7.620

Review 6.  A novel diagnostic approach to patients with myoclonus.

Authors:  Rodi Zutt; Martje E van Egmond; Jan Willem Elting; Peter Jan van Laar; Oebele F Brouwer; Deborah A Sival; Hubertus P Kremer; Tom J de Koning; Marina A Tijssen
Journal:  Nat Rev Neurol       Date:  2015-11-10       Impact factor: 42.937

Review 7.  Myoclonic Disorders.

Authors:  Olaf Eberhardt; Helge Topka
Journal:  Brain Sci       Date:  2017-08-14

8.  TBC1D24 Mutations in a Sibship with Multifocal Polymyoclonus.

Authors:  Adeline Ngoh; Jose Bras; Rita Guerreiro; Amy McTague; Joanne Ng; Esther Meyer; W Kling Chong; Stewart Boyd; Linda MacLellan; Martin Kirkpatrick; Manju A Kurian
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2017-04-13

9.  A Case of Dissociative Seizures Presented like Myoclonic Epilepsy.

Authors:  Balaswamy Reddy; Soumitra DAS; Mustafa Ali; Srinivas Guruprasad
Journal:  Shanghai Arch Psychiatry       Date:  2018-04-25

10.  Network dysfunction in α-synuclein transgenic mice and human Lewy body dementia.

Authors:  Meaghan Morris; Pascal E Sanchez; Laure Verret; Alexander J Beagle; Weikun Guo; Dena Dubal; Kamalini G Ranasinghe; Akihiko Koyama; Kaitlyn Ho; Gui-Qiu Yu; Keith A Vossel; Lennart Mucke
Journal:  Ann Clin Transl Neurol       Date:  2015-10-16       Impact factor: 4.511

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.